Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03542240 · ClinicalTrials.gov registry record · NA
Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03542240 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 15 participants.
The verdict
NCT03542240, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study will investigate the effects of curcumin on the structure/function of the body by investigating whether targeted improvement of intestinal barrier function by supplementation with oral curcumin will result in attenuation of lipopolysaccharide (LPS) translocation and/or intestinal inflammation.
Interventions
- DIETARY_SUPPLEMENT Curcumin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-09-19 |
| Est. Completion | 2020-11-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03542240
The ClinicalTrials.gov registry entry for NCT03542240 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Curcumin is the first listed.
NCT03542240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03542240 about?
NCT03542240 is a clinical study titled "Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome". This study will investigate the effects of curcumin on the structure/function of the body by investigating whether targeted improvement of intestinal barrier function by supplementation with oral curcumin will result in attenuation of lipopolysaccharide (LPS) translocation and/or intestinal inflamma...
What is the current status of trial NCT03542240?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2018-09-19. Estimated completion is 2020-11-13.
What interventions are being tested in trial NCT03542240?
The interventions under investigation include: Curcumin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03542240?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.